To test this hypothesis, we used MV4-11, a representative AML cell line carrying FLT3-ITD as well as KMT2A rearrangement, and REH, an ETV6-RUNX1+ B-ALL cell line. This evidence concerns the gene ETV6 and acute lymphoblastic leukemia.